Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F, A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss., «MOLECULAR DIAGNOSIS & THERAPY», 2019, 23, pp. 569 - 577 [articolo]
Di Nunno, V.; Mollica, V.; Gatto, L.; Santoni, M.; Sorgentoni, G.; Battelli, N.; Massari, F., Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?, «ANNALS OF TRANSLATIONAL MEDICINE», 2019, 7, pp. 38 - 42 [articolo]
Massari F.; Di Nunno V.; Mollica V.; Graham J.; Gatto L.; Heng D., Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta-Analysis of Available Clinical Trials, «CLINICAL GENITOURINARY CANCER», 2019, 17, pp. 339 - 344 [articolo]
Di Nunno, Vincenzo; Massari, Francesco; Mollica, Veronica; Cimadamore, Alessia; Santoni, Matteo; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Montironi, Rodolfo, Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma, «ANNALS OF TRANSLATIONAL MEDICINE», 2019, 7, Article number: S137, pp. 1 - 6 [articolo]Open Access
Di Nunno V.; Frega G.; Santoni M.; Gatto L.; Fiorentino M.; Montironi R.; Battelli N.; Brandi G.; Massari F., BAP1 in solid tumors, «FUTURE ONCOLOGY», 2019, 15, pp. 2151 - 2162 [articolo]
Iacovelli, Roberto; Ciccarese, Chiara; Fornarini, Giuseppe; Massari, Francesco; Bimbatti, Davide; Mosillo, Claudia; Rebuzzi, Sara Elena; Di Nunno, Vincenzo; Grassi, Massimiliano; Fantinel, Emanuela; Ardizzoni, Andrea; Tortora, Giampaolo, Cabozantinib-related cardiotoxicity: a prospective analysis in a "real world" cohort of metastatic renal cell carcinoma patients, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2019, 85, pp. 1283 - 1289 [articolo]
Massari F.; Di Nunno V., CheckMate 214 patient-reported outcomes: listening to our patients, «THE LANCET ONCOLOGY», 2019, 20, pp. 179 - 180 [articolo]
Santoni M.; Cimadamore A.; Cheng L.; Lopez-Beltran A.; Battelli N.; Massari F.; Scarpelli M.; Galosi A.B.; Bracarda S.; Montironi R., Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges, «FRONTIERS IN ONCOLOGY», 2019, 9, Article number: 228, pp. 1 - 6 [articolo]Open Access
Gasparrini S.; Cimadamore A.; Scarpelli M.; Massari F.; Doria A.; Mazzucchelli R.; Cheng L.; Lopez-Beltran A.; Montironi R., Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians, «ASIAN JOURNAL OF ANDROLOGY», 2019, 21, pp. 19 - 23 [articolo]Open Access
Cimadamore A.; Gasparrini S.; Massari F.; Santoni M.; Cheng L.; Lopez-Beltran A.; Scarpelli M.; Montironi R., Emerging molecular technologies in renal cell carcinoma: Liquid biopsy, «CANCERS», 2019, 11, Article number: 196, pp. 1 - 9 [articolo]Open Access
Prisciandaro M.; Ratta R.; Massari F., Erratum: Safety and efficacy of cabozantinib for metastatic nonclear renal cell carcinoma: Real-world data from an Italian managed access program (American Journal of Clinical Oncology: Cancer Clinical Trials (2019) 42 (42-45) DOI: 10.1097/COC.0000000000000478), «AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS», 2019, 42, pp. 412 - 412 [articolo]
Cimadamore A.; Scarpelli M.; Santoni M.; Massari F.; Tartari F.; Cerqueti R.; Lopez-Beltran A.; Cheng L.; Montironi R., Genitourinary tumors: Update on molecular biomarkers for diagnosis, prognosis and prediction of response to therapy, «CURRENT DRUG METABOLISM», 2019, 20, pp. 305 - 312 [articolo]
Di Nunno, V.; Frega, G.; Gatto, L.; Brandi, G.; Massari, F., Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: An unassessed issue, «FUTURE ONCOLOGY», 2019, 15, pp. 563 - 565 [articolo]
Di Nunno, Vincenzo; Frega, Giorgio; Gatto, Lidia; Brandi, Giovanni; Massari, Francesco, Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue, «FUTURE ONCOLOGY», 2019, 15, pp. 563 - 565 [articolo]
Massari F.; Nunno V.D.; Mollica V.; Montironi R.; Cheng L.; Cimadamore A.; Blanca A.; Lopez-Beltran A., Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice, «IMMUNOTHERAPY», 2019, 11, pp. 1507 - 1521 [articolo]
